Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Clinical Data
Pharma
Argenx gears up to launch Vyvgart in next potential indication
Argenx is bolstering its case for Vyvgart’s CIDP potential and preparing for a possible launch later this year, the company's CEO told Fierce Pharma.
Fraiser Kansteiner
Apr 16, 2024 2:24pm
Pfizer plots new RSV filing with positive Abrysvo data in adults
Apr 9, 2024 6:45am
FDA revokes approval of Oncopeptides' Pepaxto
Feb 23, 2024 11:10am
Theravance's COPD med Yupelri flunks head-to-head study
Jan 5, 2024 10:14am
An Imbruvica combo regimen could have a new future in MCL
Dec 12, 2023 12:33pm
Bayer's corporate overhaul faces new questions after trial flop
Nov 21, 2023 4:37pm